Literature DB >> 25025304

Genetic activation of mTORC1 signaling worsens neurocognitive outcome after traumatic brain injury.

Natalia S Rozas1, John B Redell, Julia L Hill, James McKenna, Anthony N Moore, Michael J Gambello, Pramod K Dash.   

Abstract

Although the mechanisms that contribute to the development of traumatic brain injury (TBI)-related deficits are not fully understood, it has been proposed that altered energy utilization may be a contributing factor. The tuberous sclerosis complex, a heterodimer composed of hamartin/Tsc-1 and tuberin/Tsc-2, is a critical regulatory node that integrates nutritional and growth signals to govern energy using processes by regulating the activity of mechanistic Target of Rapamycin complex 1 (mTORC1). mTORC1 activation results in enhanced protein synthesis, an energy consuming process. We show that mice that have a heterozygous deletion of Tsc2 exhibit elevated basal mTORC1 activity in the cortex and the hippocampus while still exhibiting normal motor and neurocognitive functions. In addition, a mild closed head injury (mCHI) that did not activate mTORC1 in wild-type mice resulted in a further increase in mTORC1 activity in Tsc2(+/KO) mice above the level of activity observed in uninjured Tsc2(+/KO) mice. This enhanced level of increased mTORC1 activity was associated with worsened cognitive function as assessed using the Morris water maze and context discrimination tasks. These results suggest that there is a threshold of increased mTORC1 activity after a TBI that is detrimental to neurobehavioral performance, and interventions to inhibit excessive mTORC1 activation may be beneficial to neurocognitive outcome.

Entities:  

Keywords:  AMPK; S6; concussion; mTBI; mTOR; memory

Mesh:

Substances:

Year:  2014        PMID: 25025304      PMCID: PMC4291161          DOI: 10.1089/neu.2014.3469

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  41 in total

1.  NR2B-dependent plasticity of adult-born granule cells is necessary for context discrimination.

Authors:  Mazen A Kheirbek; Lindsay Tannenholz; René Hen
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Inflammatory consequences in a rodent model of mild traumatic brain injury.

Authors:  J Regino Perez-Polo; Harriet C Rea; Kathia M Johnson; Margaret A Parsley; Geda C Unabia; Guojing Xu; Smitha K Infante; Douglas S Dewitt; Claire E Hulsebosch
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

Review 3.  AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

4.  Rapamycin alleviates brain edema after focal cerebral ischemia reperfusion in rats.

Authors:  Wei Guo; Guoying Feng; Yanying Miao; Guixiang Liu; Chunsheng Xu
Journal:  Immunopharmacol Immunotoxicol       Date:  2014-04-29       Impact factor: 2.730

5.  Repeated mild closed head injury impairs short-term visuospatial memory and complex learning.

Authors:  Michael J Hylin; Sara A Orsi; Natalia S Rozas; Julia L Hill; Jing Zhao; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2013-05-01       Impact factor: 5.269

Review 6.  Signal integration by mTORC1 coordinates nutrient input with biosynthetic output.

Authors:  Christian C Dibble; Brendan D Manning
Journal:  Nat Cell Biol       Date:  2013-06       Impact factor: 28.824

7.  Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model.

Authors:  Benoit C Mouzon; Corbin Bachmeier; Austin Ferro; Joseph-Olubunmi Ojo; Gogce Crynen; Christopher M Acker; Peter Davies; Michael Mullan; William Stewart; Fiona Crawford
Journal:  Ann Neurol       Date:  2014-02-20       Impact factor: 10.422

8.  Repeated mild traumatic brain injury: mechanisms of cerebral vulnerability.

Authors:  Mayumi L Prins; Daya Alexander; Christopher C Giza; David A Hovda
Journal:  J Neurotrauma       Date:  2013-01-01       Impact factor: 5.269

9.  Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat.

Authors:  Qin Lu; Lu Gao; Lijie Huang; Linhui Ruan; Jianjing Yang; Weilong Huang; Zhenxing Li; Yongliang Zhang; Kunlin Jin; Qichuan Zhuge
Journal:  J Neuroinflammation       Date:  2014-03-06       Impact factor: 8.322

10.  Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury.

Authors:  Dongjun Guo; Linghui Zeng; David L Brody; Michael Wong
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more
  8 in total

1.  Decreased rates of cerebral protein synthesis measured in vivo in a mouse model of Tuberous Sclerosis Complex: unexpected consequences of reduced tuberin.

Authors:  Rachel Michelle Saré; Tianjian Huang; Tom Burlin; Inna Loutaev; Carolyn Beebe Smith
Journal:  J Neurochem       Date:  2018-04-02       Impact factor: 5.372

2.  Multi-Dimensional Mapping of Brain-Derived Extracellular Vesicle MicroRNA Biomarker for Traumatic Brain Injury Diagnostics.

Authors:  Jina Ko; Matthew Hemphill; Zijian Yang; Kryshawna Beard; Emily Sewell; Jamie Shallcross; Melissa Schweizer; Danielle K Sandsmark; Ramon Diaz-Arrastia; Junhyong Kim; David Meaney; David Issadore
Journal:  J Neurotrauma       Date:  2019-05-06       Impact factor: 4.869

3.  Traumatic Brain Injury Stimulates Neural Stem Cell Proliferation via Mammalian Target of Rapamycin Signaling Pathway Activation.

Authors:  Xiaoting Wang; Pich Seekaew; Xiang Gao; Jinhui Chen
Journal:  eNeuro       Date:  2016-11-01

4.  Penetrating Ballistic Brain Injury Produces Acute Alterations in Sleep and Circadian-Related Genes in the Rodent Cortex: A Preliminary Study.

Authors:  Andrea Mountney; Jennifer Blaze; Zhaoyu Wang; Michelle Umali; William Jesse Flerlage; Jacqueline Dougherty; Yongchao Ge; Deborah Shear; Fatemeh Haghighi
Journal:  Front Neurol       Date:  2021-10-21       Impact factor: 4.086

5.  ILB®, a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury.

Authors:  Giacomo Lazzarino; Valentina Di Pietro; Marco Rinaudo; Zsuzsanna Nagy; Nicholas M Barnes; Lars Bruce; Stefano Signoretti; Renata Mangione; Miriam Wissam Saab; Barbara Tavazzi; Antonio Belli; Giuseppe Lazzarino; Angela Maria Amorini; Ann Logan
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

6.  IGF1-Stimulated Posttraumatic Hippocampal Remodeling Is Not Dependent on mTOR.

Authors:  Erica L Littlejohn; Anthony J DeSana; Hannah C Williams; Rudy T Chapman; Binoy Joseph; Jelena A Juras; Kathryn E Saatman
Journal:  Front Cell Dev Biol       Date:  2021-05-20

7.  A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats.

Authors:  Colleen N Bodnar; Kelly N Roberts; Emma K Higgins; Adam D Bachstetter
Journal:  J Neurotrauma       Date:  2019-03-06       Impact factor: 5.269

8.  VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury.

Authors:  Zian Xia; Wenbin Liu; Fei Zheng; Wei Huang; Zhihua Xing; Weijun Peng; Tao Tang; Jiekun Luo; Lunzhao Yi; Yang Wang
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.